BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.01 million.

BioLife Solutions reaffirmed FY2016 guidance.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.